Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era.
Ping-Hsuan HsiehOlivia WuClaudia GeueEmma McIntoshIain B McInnesStefan SiebertPublished in: Annals of the rheumatic diseases (2020)
A decreasing trend in inpatient costs chronologically suggested a cost shift in other components of direct costs. Indirect costs still contributed a considerable proportion of total costs, with work disability being the main cost component. Economic analyses that do not incorporate or appropriately measure indirect costs will underestimate the full economic impact of RA.